"Membrane Glycoproteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glycoproteins found on the membrane or surface of cells.
Descriptor ID |
D008562
|
MeSH Number(s) |
D12.776.395.550 D12.776.543.550
|
Concept/Terms |
Membrane Glycoproteins- Membrane Glycoproteins
- Glycoproteins, Membrane
- Cell Surface Glycoproteins
- Glycoproteins, Cell Surface
- Surface Glycoproteins, Cell
- Cell Surface Glycoprotein
- Glycoprotein, Cell Surface
- Surface Glycoprotein, Cell
- Surface Glycoproteins
- Glycoproteins, Surface
- Surface Glycoprotein
- Glycoprotein, Surface
- Membrane Glycoprotein
- Glycoprotein, Membrane
|
Below are MeSH descriptors whose meaning is more general than "Membrane Glycoproteins".
Below are MeSH descriptors whose meaning is more specific than "Membrane Glycoproteins".
This graph shows the total number of publications written about "Membrane Glycoproteins" by people in this website by year, and whether "Membrane Glycoproteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 9 | 4 | 13 |
1995 | 6 | 1 | 7 |
1996 | 19 | 8 | 27 |
1997 | 15 | 5 | 20 |
1998 | 16 | 12 | 28 |
1999 | 17 | 11 | 28 |
2000 | 24 | 18 | 42 |
2001 | 23 | 8 | 31 |
2002 | 29 | 21 | 50 |
2003 | 39 | 29 | 68 |
2004 | 26 | 29 | 55 |
2005 | 32 | 24 | 56 |
2006 | 16 | 16 | 32 |
2007 | 18 | 4 | 22 |
2008 | 12 | 9 | 21 |
2009 | 9 | 8 | 17 |
2010 | 14 | 6 | 20 |
2011 | 6 | 3 | 9 |
2012 | 6 | 13 | 19 |
2013 | 12 | 6 | 18 |
2014 | 6 | 8 | 14 |
2015 | 6 | 5 | 11 |
2016 | 12 | 3 | 15 |
2017 | 6 | 4 | 10 |
2018 | 7 | 3 | 10 |
2019 | 10 | 1 | 11 |
2020 | 2 | 7 | 9 |
2021 | 9 | 5 | 14 |
2022 | 1 | 5 | 6 |
2023 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Membrane Glycoproteins" by people in Profiles.
-
Tryptophan Metabolites Target Transmembrane and Immunoglobulin Domain-Containing 1 Signaling to Augment Renal Tubular Injury. Am J Pathol. 2023 10; 193(10):1501-1516.
-
Loss of the batten disease protein CLN3 leads to mis-trafficking of M6PR and defective autophagic-lysosomal reformation. Nat Commun. 2023 07 03; 14(1):3911.
-
Systematic assessment of the contribution of structural variants to inherited retinal diseases. Hum Mol Genet. 2023 06 05; 32(12):2005-2015.
-
TMEM106B regulates microglial proliferation and survival in response to demyelination. Sci Adv. 2023 05 05; 9(18):eadd2676.
-
Synaptic Loss in Spinocerebellar Ataxia Type 3 Revealed by SV2A Positron Emission Tomography. Mov Disord. 2023 06; 38(6):978-989.
-
Outcomes of anti-CD38 isatuximab plus pomalidomide and dexamethasone in five relapsed myeloma patients with prior exposure to anti-C38 daratumumab: case series. Hematology. 2022 Dec; 27(1):204-207.
-
Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens. Front Immunol. 2022; 13:977064.
-
Noninferiority of Subcutaneous Versus Intravenous Casirivimab/Imdevimab for Outpatient Treatment of SARS-CoV-2 in a Real-World Setting. Monoclon Antib Immunodiagn Immunother. 2022 Aug; 41(4):210-213.
-
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains. Nat Commun. 2022 07 02; 13(1):3824.
-
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C. Nat Commun. 2022 05 27; 13(1):2979.